Non-publication and delayed publication of randomized trials on vaccines: Survey

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Manzoli, Lamberto ^a,b   Flacco, Maria Elena ^a,c   D'Addario, Maddalena ^d   Capasso, Lorenzo ^a,b   De Vito, Corrado ^e   Marzuillo, Carolina ^e   Villari, Paolo ^e   Ioannidis, John P A ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b Department of Medicine and Aging Sciences   (Italy)

^c Local Health Unit of Pescara   (Italy)

^d UNIVERSITY OF BERN   (Switzerland)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; WART VIRUS VACCINE; BACTERIAL VACCINE; VIRUS VACCINE;

ARTICLE; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOGENICITY; INFORMATION DISSEMINATION; OUTCOME ASSESSMENT; PEER REVIEW; PREDICTION; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; BIBLIOMETRICS; FACTUAL DATABASE; PUBLISHING;

BACTERIAL VACCINES; BIBLIOMETRICS; DATABASES, FACTUAL; HUMANS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VIRAL VACCINES;

EID: 84901008703     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3058     Document Type: Article

References (47)

1. Sibbald B, Roland M. Understanding controlled trials. Why are randomised controlled trials important? BMJ 1998;316:201. (Pubitemid 28122258)
2. Manzoli L, De Vito C, Salanti G, D'Addario M, Villari P, Ioannidis JP. Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PLoS One 2011;6:e24384.
3. Leung GM, Nicoll A. Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med 2010;7.
4. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001;285:437-43. (Pubitemid 32097262)
5. Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gotzsche PC, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 2014;383:257-66.
6. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3:e3081.
7. Wu J, Li W, Wang HQ, Chen JT, Lv M, Zhou JC, et al. A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial. J Infect Dis 2010;202:675-80.
8. Ioannidis JP, Manzoli L, De Vito C, D'Addario M, Villari P. Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination. PLoS One 2011;6:e28346.
9. Scott P, Ott F, Egger M, Low N. Completeness of reporting in randomized controlled trials of 3 vaccines: a review of adherence to the CONSORT checklist. Pediatr Infect Dis J 2012;31:1286-94.
10. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ 2013;347:f6104.
11. Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, et al. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 2008;26:6630-8.
12. Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med 2013;10:e1001566; discussion e66.
13. Galsworthy MJ, Hristovski D, Lusa L, Ernst K, Irwin R, Charlesworth K, et al. Academic output of 9 years of EU investment into health research. Lancet 2012;380:971-2.
14. Gordon D, Taddei-Peters W, Mascette A, Antman M, Kaufmann PG, Lauer MS. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med 2013;369:1926-34.
15. Krzyzanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 2003;290:495-501. (Pubitemid 37430503)
16. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 2008;5:e191.
17. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 2008;5:e217; discussion e17.
18. Turner EH, Knoepflmacher D, Shapley L. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med 2012;9:e1001189.
19. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60.
20. Van de Wetering FT, Scholten RJ, Haring T, Clarke M, Hooft L. Trial registration numbers are underreported in biomedical publications. PLoS One 2012;7:e49599.
21. Dickersin K, Min YI. NIH clinical trials and publication bias. Online J Curr Clin Trials 1993;Doc No 50.
22. Turner S, Wright D, Maeso R, Cook A, Milne R. Publication rate for funded studies from a major UK health research funder: a cohort study. BMJ Open 2013;3(5).
23. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 1992;267:374-8.
24. Patsopoulos NA, Ioannidis JP. The use of older studies in meta-analyses of medical interventions: a survey. Open Med 2009;3:e62-8.
25. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Fortaleza, Brasil: 64th WMA General Assembly, 2013.
26. Strech D. Normative arguments and new solutions for the unbiased registration and publication of clinical trials. J Clin Epidemiol 2012;65:276-81.
27. Chalmers I. Underreporting research is scientific misconduct. JAMA 1990;263:1405-8. (Pubitemid 20069949)
28. Federal Policy for the Protection of Human Subjects: Code of Federal Regulations (CFR), 2009.
29. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:d7292.
30. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, et al. Biomedical research: increasing value, reducing waste. Lancet 2014;383:101-4.
31. Manzoli L, Salanti G, De Vito C, Boccia A, Ioannidis JP, Villari P. Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. Lancet Infect Dis 2009;9:482-92.
32. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009;1:MR000006.
33. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997;315:640-5. (Pubitemid 27387174)
34. Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171:735-40. (Pubitemid 39319090)
35. Decullier E, Chapuis F. Impact of funding on biomedical research: a retrospective cohort study. BMC Public Health 2006;6:165.
36. Decullier E, Lheritier V, Chapuis F. Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ 2005;331:19.
37. Ioannidis JP. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998;279:281-6.
38. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72.
39. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 2009;6:e1000144.
40. Von Elm E, Rollin A, Blumle A, Huwiler K, Witschi M, Egger M. Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee. Swiss Med Wkly 2008;138:197-203. (Pubitemid 351533228)
41. Shamliyan T, Kane RL. Clinical research involving children: registration, completeness, and publication. Pediatrics 2012;129:e1291-300.
42. Young NS, Ioannidis JP, Al-Ubaydli O. Why current publication practices may distort science. PLoS Med 2008;5:e201.
43. Goodman SN, Berlin J, Fletcher SW, Fletcher RH. Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med 1994;121:11-21.
44. Cobo E, Selva-O'Callagham A, Ribera JM, Cardellach F, Dominguez R, Vilardell M. Statistical reviewers improve reporting in biomedical articles: a randomized trial. PLoS One 2007;2:e332.
45. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
46. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153:158-66.
47. Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009;361:1963-71.